The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute ...

Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...

The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute myocardial infarction (AMI) and unstable angina, an aging global population ...

Monica Embers is the co-founder of Aces Diagnostics, a Lyme disease testing company. which has developed a test that is over ...

The action affects the TROPOS trial of cibotacept (KER-012), an activin signalling inhibitor that works in a similar way to ...

USA: A recent post hoc analysis of two randomized clinical trials has provided insight into the role of C-reactive protein ...